BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27226604)

  • 1. Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma.
    Holmes B; Lee J; Landon KA; Benavides-Serrato A; Bashir T; Jung ME; Lichtenstein A; Gera J
    J Biol Chem; 2016 Jul; 291(27):14146-14159. PubMed ID: 27226604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
    Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
    J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Benavides-Serrato A; Saunders JT; Kumar S; Holmes B; Benavides KE; Bashir MT; Nishimura RN; Gera J
    Cancer Lett; 2023 May; 562():216178. PubMed ID: 37061119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphomimetic substitution of heterogeneous nuclear ribonucleoprotein A1 at serine 199 abolishes AKT-dependent internal ribosome entry site-transacting factor (ITAF) function via effects on strand annealing and results in mammalian target of rapamycin complex 1 (mTORC1) inhibitor sensitivity.
    Martin J; Masri J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Anderson L; Bashir T; Bernath A; Lichtenstein A; Gera J
    J Biol Chem; 2011 May; 286(18):16402-13. PubMed ID: 21454539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastoma.
    Cloninger C; Bernath A; Bashir T; Holmes B; Artinian N; Ruegg T; Anderson L; Masri J; Lichtenstein A; Gera J
    Mol Cancer Ther; 2011 Dec; 10(12):2244-56. PubMed ID: 21911485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.
    Shi Y; Sharma A; Wu H; Lichtenstein A; Gera J
    J Biol Chem; 2005 Mar; 280(12):10964-73. PubMed ID: 15634685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma.
    Benavides-Serrato A; Saunders JT; Holmes B; Nishimura RN; Lichtenstein A; Gera J
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling.
    Jo OD; Martin J; Bernath A; Masri J; Lichtenstein A; Gera J
    J Biol Chem; 2008 Aug; 283(34):23274-87. PubMed ID: 18562319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.
    Gao G; Dhar S; Bedford MT
    Nucleic Acids Res; 2017 May; 45(8):4359-4369. PubMed ID: 28115626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress.
    Shi Y; Yang Y; Hoang B; Bardeleben C; Holmes B; Gera J; Lichtenstein A
    Oncogene; 2016 Feb; 35(8):1015-24. PubMed ID: 25961916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
    Shi Y; Sun F; Cheng Y; Holmes B; Dhakal B; Gera JF; Janz S; Lichtenstein A
    Mol Cancer Ther; 2022 Apr; 21(4):502-510. PubMed ID: 35086951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.
    Shi Y; Frost PJ; Hoang BQ; Benavides A; Sharma S; Gera JF; Lichtenstein AK
    Cancer Res; 2008 Dec; 68(24):10215-22. PubMed ID: 19074889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
    Shi Y; Frost P; Hoang B; Yang Y; Fukunaga R; Gera J; Lichtenstein A
    Oncogene; 2013 Jan; 32(2):190-7. PubMed ID: 22370634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A2 binds the internal ribosomal entry site of c-
    Strand E; Hollås H; Sakya SA; Romanyuk S; Saraste MEV; Grindheim AK; Patil SS; Vedeler A
    RNA Biol; 2021 Oct; 18(sup1):337-354. PubMed ID: 34346292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNP K Is a Novel Internal Ribosomal Entry Site-Transacting Factor That Negatively Regulates Foot-and-Mouth Disease Virus Translation and Replication and Is Antagonized by Viral 3C Protease.
    Liu W; Yang D; Sun C; Wang H; Zhao B; Zhou G; Yu L
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-site binding inhibitor effectively targets mTORC1 and mTORC2 complexes in glioblastoma.
    Neil J; Shannon C; Mohan A; Laurent D; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2016 Mar; 48(3):1045-52. PubMed ID: 26719046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.
    Tsai BP; Jimenez J; Lim S; Fitzgerald KD; Zhang M; Chuah CT; Axelrod H; Wilson L; Ong ST; Semler BL; Waterman ML
    Open Biol; 2014 Nov; 4(11):140180. PubMed ID: 25392452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin.
    Frost P; Shi Y; Hoang B; Gera J; Lichtenstein A
    Mol Cancer Ther; 2009 Jan; 8(1):83-93. PubMed ID: 19139116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sST2 translation is regulated by FGF2 via an hnRNP A1-mediated IRES-dependent mechanism.
    Kunze MM; Benz F; Brauß TF; Lampe S; Weigand JE; Braun J; Richter FM; Wittig I; Brüne B; Schmid T
    Biochim Biophys Acta; 2016 Jul; 1859(7):848-59. PubMed ID: 27168114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 regulates cyclin D1 and c-MYC transcription in an AKT-dependent manner in response to mTOR inhibition: role of AIP4/Itch-mediated JUNB degradation.
    Vartanian R; Masri J; Martin J; Cloninger C; Holmes B; Artinian N; Funk A; Ruegg T; Gera J
    Mol Cancer Res; 2011 Jan; 9(1):115-30. PubMed ID: 21135252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.